CSIMarket Company Name, Ticker, Customers, else..
 
Telomir Pharmaceuticals Inc   (NASDAQ: TELO)
Other Ticker:  
 
 
Price: $5.1000 $-0.48 -8.602%
Day's High: $5.66 Week Perf: -8.44 %
Day's Low: $ 5.00 30 Day Perf: 20.85 %
Volume (M): 219 52 Wk High: $ 9.39
Volume (M$): $ 1,115 52 Wk Avg: $5.32
Open: $5.58 52 Wk Low: $3.11



 Market Capitalization (Millions $) 151
 Shares Outstanding (Millions) 30
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Telomir Pharmaceuticals Inc


   Company Address: 900 W Platt Street Tampa 33606 FL
   Company Phone Number: 864-2558   Stock Exchange / Ticker: NASDAQ TELO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GERN      0% 
OMER   -21.81%    
• View Complete Report
   



Clinical Study

Telomir Pharmaceuticals Joins Russell 3000 and Microcap Indexes, Strengthening Position in Pharmaceutical Market

Published Tue, Jul 2 2024 12:30 PM UTC

TAMPA, Fla., July 02, 2024 - Telomir Pharmaceuticals, Inc. (Nasdaq: TELO), a pre-clinical-stage pharmaceutical company specializing in the development and commercialization of Telomir-1, a revolutionary small molecule aimed at lengthening the protective telomere caps of DNA, has been included as a member of the prestigious Russell 3000 and Russell Microcap Indexes. This lat...
Clinical Study

Telomir Pharmaceuticals Achieves Crucial Milestones in Safety Evaluation of Telomir-1 o...

Published Thu, May 30 2024 12:30 PM UTC

Telomir Pharmaceuticals, a leading biopharmaceutical company, is thrilled to announce two significant milestones in the development of their flagship product candidate, Telomir-1. The company has commenced a groundbreaking study to evaluate the safety of Telomir-1 when administered orally to geriatric laboratory beagle dogs for 63 consecutive days, marking a crucial step tow...
Clinical Study

Telomir-1: Unlocking the Secrets of Cellular Aging -Telomir Pharmaceuticals Presents Groundbreaking Pre-Clinical Data at Global Longevity Federation Conference

Published Fri, Mar 22 2024 12:30 PM UTC

The press release highlights that the upcoming poster presentation at the conference will unveil the promising results of Telomir-1 in elongating telomere caps on human normal embryonic fibroblast cells. These telomere caps, located at the ends of chromosomes, serve as protective layers that prevent the erosion and degradation of genetic material during cell division. As cel...
Product Service News

Telomir Pharmaceuticals Pioneering Age Reversal Science with Breakthrough AI Testing Models

Published Thu, Mar 14 2024 12:30 PM UTC

In the perpetual pursuit of the fountain of youth, Telomir Pharmaceuticals is pioneering a groundbreaking approach to age reversal science. Leveraging the power of artificial intelligence (AI) testing models, the company's lead product candidate, Telomir-1, has demonstrated remarkable potential in extending DNA telomeres to reverse age-related conditions. This breakthrough d...
Clinical Study

Revolutionary Breakthrough: Telomir-1 Shows Promising Pre-Clinical Data in Elongating Telomeres and Targeting Age-Related Inflammatory Conditions

Published Thu, Mar 7 2024 1:30 PM UTC

Telomir Pharmaceuticals Presents Exciting Pre-Clinical Data on Telomir-1 at Singapore ConferenceTelomir Pharmaceuticals, in collaboration with Frontage Laboratories, recently unveiled groundbreaking pre-clinical data on their lead development product, Telomir-1, at a prestigious Singapore conference. Telomir's poster presentation captivated the audience, highlighting the pro...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com